Amanote Research

Amanote Research

    RegisterSign In

Vigabatrin

Neurotherapeutics - United States
doi 10.1016/j.nurt.2006.11.008
Full Text
Open PDF
Abstract

Available in full text

Categories
NeurologyPharmacology
Date

January 1, 2007

Authors
James W. WhelessR. Eugene RamsayStephen D. Collins
Publisher

Springer Science and Business Media LLC


Related search

Vigabatrin.

BMJ
1990English

Evaluating Risks for Vigabatrin Treatment

Epilepsy Currents
Neurology
2009English

Visual Field Loss Associated With Vigabatrin: Pathological Correlations

American Journal of Ophthalmology
Ophthalmology
2001English

Vigabatrin, Tiagabine, and Visual Fields

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2003English

Vigabatrin and Mental Retardation in Tuberous Sclerosis

Journal of Child Neurology
Child HealthNeurologyPediatricsPerinatology
2012English

Visual Field Defects Associated With Vigabatrin Monotherapy in Children

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2000English

Limiting Retinal Toxicity of Vigabatrin in Children With Infantile Spasms

Epilepsy Currents
Neurology
2015English

Response to Vigabatrin in Relation to Seizure Type.

British Journal of Clinical Pharmacology
Pharmacology
1989English

Changes in the Electroretinogram Resulting From Discontinuation of Vigabatrin in Children

Documenta Ophthalmologica
OphthalmologySensory SystemsPhysiology
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy